The effects of suramin on phagolysosome formation and antimicrobial activity of mouse peritoneal macrophages cultivated in vitro have been studied. Prolonged in vitro pretreatment of macrophages with high concentrations of suramin caused macrophages to form large fragile phagolysosomes in which the concentrations of the various lysosomal enzymes were inferred to be diminished. In addition, suramin-treated macrophages demonstrated enhanced exocytosis of acid phosphatase during phagocytosis of polyvinyl toluene spherules. However, suramin was found not to inhibit formation of phagolysosomes in macrophages that had ingested Listeria monocytogenes when those cells were examined by the electron microscope. Suramin pretreatment did not alter the ingestion or intracellular killing of Staphylococcus aureus or of a strain of L. monocytogenes that was essentially avirulent for mice, but did protect macrophages from destruction by virulent L. monocytogenes ingested in vitro, an effect that appeared to have been mediated through enhancement of the bacteriostatic potential of the macrophages. However, at a single dosage level, the drug did not alter the mortality of mice challenged with virulent L. monocytogenes.
The mechanisms involved in the antimicrobial activity of macrophages have not been established (6) . Lysosomal contents, for example myeloperoxidase, contribute to the antimicrobial activity of polymorphonuclear leukocytes (27) , but the role of lysosomes in macrophage antimicrobial activity has not been defined. Although lack of fusion of lysosomes with phagosomes in macrophages correlates well with intracellular growth of ingested parasites in some circumstances (1, 15) , it has been shown that enhancement of lysosomal fusion is not sufficient to promote enhanced macrophage antimycobacterial activity (2). If phagolysosome formation could be pharmacologically blocked, then the role of lysosomes in macrophage antimicrobial activity could be more accurately assessed. Numerous drugs such as colchicine (21, 34) and glucocorticoids (30) have been thought to stabilize lysosomes and/or prevent fusion of lysosomes with phagosomes, but only suramin (13) , mycobacterial sulfatides (10) , and concanavalin A (8) have been alleged to manifest that activity in intact phagocytes.
Suramin is a sulfonated derivative of urea, chemically related to the dye trypan blue, which has long been used in the therapy and prophylaxis of African trypanosomiasis (31) . It is strongly protein bound and is concentrated within lysosomes, probably as a result of endocytosis of suramin-protein complexes (7) . In prior studies of the effects of the drug on antibacterial immunity, suramin was shown to have a detrimental effect on host-cell antibacterial activity both in vivo (24, 33) and in vitro (11) . However, a potentially beneficial effect on induction of cellular immunity by killed organisms has recently been described (29) . Because suramin concentrates intralysosomally, and because other intralysosomally stored agents, e.g. trypan blue (17) and hydroxystilbamidine (9) , may alter macrophage function, it seemed reasonable to assume that suramin's effects are indeed mediated by its effects on lysosomal function, primarily inhibition of phagolysosome formation (13 Macrophages. Unstimulated peritoneal macrophages were harvested by lavage with 0.01 M heparinized phosphate-buffered saline (PBS) (pH 7.4) using methods previously described (4) . Macrophages were maintained as monolayers in Leighton tubes or tissue culture flasks in medium 199 supplemented with heatinactivated newborn calf serum (20%) and penicillin G 504 PESANTI (1,000 U/ml) in an atmosphere containing 95% air and 5% CO2 at 37°C. The medium was changed at 1 and 24 h after harvest of cells and then every 2 to 3 days. Cell viability was determined by use of trypan blue (22) and acridine orange (25) For in vitro studies utilizing bacteria, macrophage monolayers were first rinsed with medium 199 and incubated for 1 h in medium containing 100 U of penicillinase (Difco Laboratories) per ml; the medium was then aspirated, and fresh medium containing bacteria was added. Phagocytosis was terminated by aspiration of medium, rinsing three times with medium 199, and addition of fresh medium containing antibiotics. Lysostaphin (2 U/mi) (Schwartz/Mann) was used in experiments with staphylococci, and penicillin (2 U/ml) plus gentamicin (1 ug/ml) was used in experiments with Listeria. Bacteria were quantitated by determining the number of colonies forming on brain heart infusion agar from suitably diluted samples of medium and distilled water (18) , using crystalline egg-white lysozyme as the standard.
Phagolysosome formation. The effects of suramin on macrophage phagolysosome formation were assessed by fluorescent and electron microscopy and by assay of transfer of acid phosphatase to PVT-containing phagolysosomes and exocytosis of acid phosphatase. Macrophages to be studied with fluorescent microscopy were incubated in medium containing acridine orange (10 ytg of base per ml) for 15 min and rinsed with medium 199; this resulted in intense fluorescent staining of lysosomes (13) . Following addition of particles in fresh medium, transfer of dye to vacuoles containing the particles was monitored over time with a Leitz transmitted-light fluorescent microscope. The percentage of ingested particles that became stained was quantitated only in experiments using yeast cells, because interiorized yeasts were visible whether or not lysosomal fusion had occurred, whereas bacteria not coated with acridine orange were poorly resolved.
For electron microscopy, macrophages were allowed to ingest cadmium-free ferritin (5 mg/ml) (Miles Laboratories) for 24 h. Subsequent to removal of ferritin, macrophages were cultivated for an additional 6 days in the presence or absence of suramin (200 ,g/ml). L. monocytogenes (Lo or Lm) was added at a final concentration of 5 x 107/ml to rinsed monolayers. At varying times after addition of bacteria, the medium was removed and the macrophages were rinsed with PBS and fixed overnight with 2% glutaraldehyde in cacodylate buffer (0.1 M) at 4°C. The cells were then scraped from flasks, sedimented at 250 x g at room temperature, rinsed in cacodylate buffer, and postfixed in osmium tetroxide. Following dehydration in ethanol, the cells were embedded in Epon. Because uranyl acetate staining made recognition of ferritin more difficult, most preparations were not stained.
Exocytosis of acid phosphatase was assayed in monolayers that had ingested PVT (5 x 107/ml) for 2 h in Earle balanced salt solution without neutral red plus 20% newborn calf serum and penicillin. At the end of phagocytosis, medium was decanted and filtered and cells were rinsed with PBS. Both portions were subjected to five freeze-thaw cycles and assayed for acid phosphatase activity using a-naphthol acid phosphate (Dajac Laboratories) as a substrate. Triton X-100 was incorporated in the reaction mixture for the cell samples but was omitted for the medium samples (34) . Labile enzyme activity in medium is expressed as percentage of total enzyme activity (enzyme activity in monolayer plus labile enzyme in medium).
The transfer of acid phosphatase to phagolysosomes containing PVT was quantitated using previously described methods (21) . Briefly, macrophages that had ingested PVT were washed with PBS, removed from culture flasks by scraping, and disrupted with a Dounce homogenizer. Following sedimentation of nuclei and undisrupted cells by centrifugation at 2,500 x g for 10 min, the supernatant was layered onto a INFECT. IMMUN.
on October 18, 2017 by guest http://iai.asm.org/ Downloaded from discontinuous sucrose gradient (5 to 10 to 27.5% sucrose, wt/vol) and centrifuged for 1 h at 25,000 x g at 4°C. Unfused lysosomes settled at the 27.5 to 50% interface, while PVT-containing phagosomes and phagolysosomes floated to the 5 to 10% sucrose interface. Lysosomal contents released during processing remained in the 27.5% layer. Acid phosphatase activity in each fraction was expressed as percentage of total activity recovered from the gradient and was normalized for uptake of PVT per microgram of cell protein.
In vivo studies. Mice received suramin in 0.2 ml of PBS intravenously at 3-day intervals; two doses were given before infection and two after. L. monocytogenes (Lm) was also administered by tail vein injection. The LD50 of Listeria and of suramin was determined by the method of Reed and Muench (23), and then the interaction of the two agents was studied.
Data analysis. Microscopic counts were performed on coded slides or tubes. Unless otherwise specified, results represent means and standard errors of duplicate or triplicate values of three or more experiments. Straight lines were generated by the method of leastmean-squares linear-regression analysis. Differences among means of proportions were calculated by Student's t test for unpaired data, while differences among counts were determined by the x2 test with continuity correction. A two-tailed P c 0.05 was considered statistically significant.
RESULTS
Suramin was well tolerated by macrophages in culture as long as the concentration of the drug did not exceed 200 ,tg/ml and fresh drug was added no more frequently than every other day. However, extensive cell loss followed exposure to 400 ,ug/ml for 18 h or to 200 ,ug/ml within 3 days if fresh drug was added on a daily basis. Macrophages treated with suramin (100 to 200 ,ug/ml) developed numerous large phaselucent vacuoles reminiscent of those seen after ingestion of undigestible carbohydrates by macrophages (5). At the electron microscopic level, the vacuoles contained membranous whorls and, in ferritin-loaded preparations, contained ferritin (Fig. 1) .
Preliminary experiments indicated that prolonged in vitro pretreatment was necessary for suramin to alter transfer of acridine orange to phagolysosomes. The effect was best seen after 3 days of exposure and was not further enhanced by longer preincubation; there was no apparent difference among exposure times between 3 and 6 days, and data from these periods were pooled. As determined by fluorescent microscopy, pre- to phagosomes in macrophages that had interiorized either Saccharomyces ( Fig. 2A) (13) or either strain of L. monocytogenes. It was evident that extensive fusion had occurred in control macrophages ingesting Listeria. Suramintreated macrophages ingesting bacteria normally but only rarely (less than 1/500 macrophages, under conditions in which every cell contained bacteria) contained a stained bacterium. There was no apparent difference between Lo and Lm in these observations.
The drug also altered transfer of acid phosphatase to PVT-containing phagolysosomes (Fig. 3) , causing a marked difference in transfer of enzyme to phagolysosomes. The inhibition of transfer was not evident in cells that had been pretreated for less than 48 h, but was seen in cells that had been pretreated for at least 3 days. However, concomitant with inhibition of transfer of acid phosphatase to phagocytic vacuoles, an increase in the proportion of the enzyme that remained in the 27.5% sucrose layer was noted. In cells pretreated with suramin for 3 or more days, 18.5 ± 2.1% of total enzyme activity did not migrate, compared to 4.9 ± 0.9% in control preparations (P < 0.01). This fraction represents enzyme activity labilized during preparation and presumably indicates that the morphological changes in lysosomes evident microscopically ( Fig. 1) The results of the experiments reported thus far were compatible with the hypothesis that suramin inhibited intracellular phagolysosome formation in normal peritoneal macrophages. However, electron micrographs of ferritinloaded macrophages indicated that, although lysosomal morphology was altered by treatment with the drug and the ferritin was much less densely aggregated within dilated lysosomes, there was fusion of lysosomes with phagosomes following ingestion of living Listeria of either strain (Fig. 1) . For these studies, macrophages treated with suramin (200 ,Ig/ml for 6 days) were allowed to ingest Listeria for periods of time varying from 15 min to 2 h. Specimens were scanned electron microscopically, and 30 to 50 interiorized bacteria were identified and assessed for presence or absence of surrounding ferritin in each of six experiments. Photomicrographs were made of bacteria around which the pres-which ferritin was present, suggesting that phagolysosome formation had occurred virtually simultaneously with phagocytosis. There were no obvious differences in the behavior of macrophages toward either strain of Listeria; the virulent strain, which kills normal macrophages, was found to reside within phagolysosomes within 15 min (the earliest time studied) of initiation of phagocytosis both in control and suramin-treated preparations. In addition to these effects on lysosomal morphology, the drug apparently altered the ingestive process such that multiple bacteria were often noted to reside within single large vacuoles, a phenomenon seldom observed in untreated macrophages.
While these studies were in progress, the effects of suramin pretreatment on macrophage endocytosis and antimicrobial activity were evaluated.
[3H]sucrose uptake, a measure of pinocytosis (20) , was unimpaired, as was ingestion of PVT (Fig. 4) . In addition, treated macrophages accumulated as many bacteria (Fig. 5 ) and yeasts as did controls. There was no effect on macrophage fungicidal activity as determined by methylene blue dye exclusion (Fig. 2B) , nor was the ability of the macrophages to inactivate Listeria (Lo) or S. aureus impaired (Fig. 5) .
However, when macrophages were challenged in vitro with a dose of Listeria (Lm) sufficient to infect at least 95% of the cells within 1 h, macrophages pretreated with suramin were protected from death due to Listeria infection. As illustrated in Fig. 6 Survival of macrophages at 24 h after challenge with L. monocytogenes (Lm). Control (0) and suramin-treated (A) macrophages were exposed to L. monocytogenes (Lm) at a concentration of Id organisms per ml for 1 h. The medium was aspirated, the tubes were rinsed, and fresh medium containing penicillin (2 U/ml) and gentamicin (1 [Lg/ml) was added.
The number of cells in each tube was determined by phase-contrast microscopy using an eyepiece grid at 1 h and 24 h, and the viability of cells at 24 h was determined by vital stains. Suramin at 100 and 200 jig/ml significantly (P < 0.05) reduced destruction of macrophages.
the drug on fraction of cells infected (since a decrease in that parameter could falsely suggest protection), macrophages were exposed to differing inocula of Listeria (Lm), and the percentage of cells infected and subsequent formation of intracellular microcolonies (19) 7 h after termination of phagocytosis were assessed. Suramin pretreatment did not affect the percentage of cells infected (Fig. 7) Macrophages were allowed to ingest Listeria at the stated inoculum in antibiotic-free medium for 1 h. Phagocytosis was terminated by aspiration of the medium, repeated rinsing, and addition of medium containing penicillin (2 U/ml) and gentamicin (1 jig/ml).
After incubation for an additional 6 h, monolayers on coverslips were extracted, rinsed, air dried, fixed in methanol, and stained with Giemsa stain. At least 200 macrophages containing 1 or more Listeria were counted, and macrophages containing discrete clumps of organisms or over 10 organisms dispersed throughout the cytoplasm were considered to contain microcolonies. Macrophages pretreated with 200 ,ug of suramin per ml (S200) allowed significantly less replication than either control macrophages or those that had been pretreated with 50,ug of the drug per ml (S50). P < 0.05. e P < 0.01. mals treated with suramin (28) , some data suggest that suramin alters host responses to bacterial infections (24, 29, 33) . In preliminary experiments, the LD5o of the drug when administered intravenously four times at 3-day intervals was found to be 8 mg per mouse (-300 mg/kg per dose). In an attempt to minimize nonspecific interactions between a toxic drug and infection (26) , the dose was limited to 2 mg per injection (1/4 LD50), which is similar to the doses used by others (24, 33) . Suramin did not affect mortality or time to death of mice infected intravenously with L. monocytogenes (Lm) at a dose calculated to be 1 LD50 (Fig. 8) .
Moreover, peritoneal macrophages lavaged from suramin-treated mice did not manifest the morphological changes observed in cells treated in vitro, transferred acridine orange to phagolysosomes normally, and were indistinguishable from normal macrophages in in vitro infection with Listeria (Lm).
DISCUSSION
These studies were conducted in an attempt to confirm and further define the inhibition of phagolysosome formation first observed in suramin-treated macrophages by Hart and Young (13) . The mechanisms involved in macrophage antimicrobial activity have not been delineated (6) , and satisfactory hypotheses to explain the increase in activity that accompanies macrophage activation do not exist. Because polymorphonuclear leukocytes kill bacteria and yeasts by mechanisms which require participation of lysosomal contents (27) If lysosomal fusion could be blocked, the role of lysosomal contents in macrophage antimicrobial activity could be better defined. Many of the drugs that had been thought to inhibit phagolysosome formation, for example colchicine and glucocorticoids, because of their effects on stability of isolated lysosomes or on exocytosis of lysosomal enzymes, have been shown not to inhibit phagolysosome formation in intact macrophages (13, 21, 30) . Suramin, however, was shown to inhibit phagolysosome formation by macrophages that had ingested live Saccharomyces (13) , but the effects of the drug on macrophage phagolysosome formation and bactericidal activity following ingestion of an intracellular parasite have not been previously described.
Previous in vivo and in vitro studies with suramin and its analogs have suggested that at least part ofits many pharmacological properties may result from effects on lysosomes. It has been shown to accumulate within lysosomes, for example, in renal tubular epithelial cells in animals given suramin (14) , and it is capable of inhibiting the action of a wide variety of enzyme systems, lysosomal and other (32) . In prior studies of the effects of suramin on host defenses, macrophages treated in vitro with suramin (dose and timing not specified) allowed more rapid replication of interiorized M. tuberculosis (11) , and the drug enhanced mortality in murine tuberculosis (24) . The recent demonstration (13) of inhibition of phagolysosome formation following ingestion of live yeast by suramin-treated macrophages further strengthened the hypothesis that effects on host defenses were secondary to effects of the drug on phagolysosome formation.
However, the studies of ferritin-loaded macrophages reported here clearly demonstrate that phagolysosome formation was not blocked in suramin-treated macrophages that had ingested the intracellular pathogen L. monocytogenes. The drug did cause formation of "loose" phagolysosomes, as had been previously described (6) , resulted in formation of autophagic vacuoles, and seemed to increase the number of phagolysosomes containing multiple bacteria. The electron microscope observations thus did not confirm those made with the fluorescent light microscope concerning the behavior of lysosomes in suramin-treated cells ingesting Listeria. The most likely explanation for this difference seems to be that the concentration of transferred dye was insufficient to cause visible fluorescence in phagolysosomes in treated cells as well as in a significant percentage of phagolysosomes in control cells. Two observations support this concept. First, when the dye was dissolved in saline and placed on a microscope slide, the characteristic fluorescence was not microscopically visible until the concentration of the dye exceeded 500 Ag/ml; thus, the dye had to have been concentrated in phagolysosomes at least 50-fold over its initial concentration in the medium for fluorescence to be microscopically detectable. In addition, in control macrophages, it was noted that even after in vitro incubation with yeast cells for up to 6 h, approximately one-third of the interiorized yeast had not acquired the fluorescent label. It is difficult to imagine that yeast, over 90% of which were dead by that time, could long remain within normal macrophages without lysosomal fusion having occurred, either prior or subsequent to death of the yeast. Thus, the acridine orange technique is probably useful only as a screening tool for phagolysosome formation, and is valid only if it indicates that fusion occurs in treated cells to the same extent as that observed in control cells.
Similarly, the studies of transfer of acid phosphatase to PVT-containing phagolysosomes were difficult to interpret in suramin-treated macrophages. One of the assumptions of that technique is that the procedures used to disrupt the cells cause similar damage to treated and to control macrophages. This assumption was not valid in these experiments. The widely dilated vacuoles in treated macrophages, loosely applied to ingested particles, were excessively fragile. This resulted in a high fraction of the total enzyme activity remaining in the 27.5% sucrose layer. Even accounting for that loss of potentially transferable activity, the amount of enzyme activity transferred to the phagolysosome layer at high particle loads seemed diminished, although the data do not allow firm conclusions to be drawn.
The other biochemical technique used to evaluate the effect of suramin on lysosomal fusion was the study of exocytosis oflysosomal enzymes accompanying ingestion of latex beads. Since both phagolysosome formation and exocytosis involve fusion of lysosomes with portions of the VOL. 20, 1978 on October 18, 2017 by guest http://iai.asm.org/ PESANTI cell membrane, it has been assumed that drugs that inhibit exocytosis also inhibit phagolysosome formation (34) . At all concentrations tested, including those which had no effect on the behavior of virulent Listeria infections in vitro or on acridine orange transfer, suramin pretreatment enhanced exocytosis. Although these results may seem disparate with some of the former observations, they can be rendered compatible if it is assumed that, instead of inhibiting phagolysosome formation, suramin actually accelerated the process. Thus, during phagocytosis, lysosomes may have fused with plasma membranes prior to complete encirclement of the particles, with resultant leakage of the enzyme into the medium. This would result in the relatively sparse concentrations to ferritin seen in electron micrographs, and would also result in diminished intralysosomal concentrations of acridine orange and loss of fluorescence. Thus, it remains probable that phagolysosome formation is altered in suramin-treated macrophages such that ingested particles were exposed to lesser concentrations of active lysosomal contents; inhibition, in the sense that particles do not contact lysosomal contents at all, was not observed.
Since the drug did not completely block lysosomal fusion with phagocytic vacuoles, the lack of effect of suramin treatment on the behavior of bacteria of low virulence for murine macrophages is not unexpected, nor does the observation aid in discerning mechanisms of macrophage antimicrobial activity. However, the protection of macrophages against destruction by virulent Listeria, which resulted from prolonged in vitro pretreatment of macrophages with high concentrations of suramin, was unexpected both from prior published data on the drug's effects and from the other results reported here. There were certain analogies between the protective effect and the effects of acridine orange transfer, suggesting that the drug had to have been interiorized by macrophages to be effective. For the protection to be evident, high concentrations present in medium for at least 3 days were required; drug added to untreated macrophages after the cells were infected was without effect, and continued presence of suramin in the medium was not required for the effects to be manifest. These observations suggest that the protective effect was mediated through effects of the drug on lysosomes, but do not rule out other possibilities, for example alterations in other enzyme systems or in the cell membrane.
Because suramin pretreatment protected macrophage monolayers in vitro, in vivo trials were attempted. Although the concentrations of drug used in vitro would have been rapidly fatal INFECT. IMMIJN. in vivo, it was hoped that perhaps at least some of the effect would manifest itself in vivo. Because it is well known that suramin's toxic-therapeutic ratio is relatively low (31) , and because it has been shown that even definitely beneficial drugs, such as antibiotics, can be harmful to mice with bacterial infections if used at doses too near their LD50 (26) , dosage of suramin was limited to one-fourth the LD50. At those doses, the drug was neither helpful nor detrimental. It remains possible that the in vitro effects could be produced in vivo if the drug is administered chronically to allow greater intralysosomal accumulation in macrophages, since continued pinocytosis of low levels could conceivably, over much longer periods of time, result in accumulation of effective intracellular concentrations of the drug.
In conclusion, the effects of suramin on murine macrophage function were found to be complex and not mediated by drug-induced blockade of phagolysosome formation. Although the transfer of lysosomal contents to phagosomes in suramin-treated macrophages may be somewhat diminished compared with that in untreated cells, the drug did not block phagolysosome formation such that the intracellular fate of Listeria not exposed to lysosomal enzymes could be determined. Inhibition of phagolysosome formation in intact cells remains an elusive goal. At doses of suramin that seemed to diminish the concentration of lysosomal contents in phagolysosomes (as inferred from acridine orange transfer and ferritin studies), intracellular growth of a virulent strain of L. monocytogenes was suppressed. Whether this reflects activation of macrophages, an alteration in lysosomal contents that Listeria somehow utilizes in its intracellular growth, alterations in macrophage membrane permeability to 
